Eaton Vance Management Bristol Myers Squibb CO Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eaton Vance Management holds 7,129,326 shares of BMY stock, worth $363 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
7,129,326
Previous 7,297,215
2.3%
Holding current value
$363 Million
Previous $562 Million
9.8%
% of portfolio
0.75%
Previous 0.79%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.08 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.66 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.8 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.01 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $108B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...